Home » Authors » Holland Johnson

Articles by Holland Johnson

Rising costs, regulatory quagmire make medical future uncertain

Dec. 1, 2004

By Holland Johnson

Cardio innovation in the clinical setting is explored at conference

Dec. 1, 2004

By Holland Johnson

Vitex Stock Falls On Enrollment Suspension In Inactine Phase III

Nov. 29, 2004

By Holland Johnson

Vitex Stock Falls On Enrollment Suspension In Inactine Phase III

Nov. 29, 2004

By Holland Johnson

GE Healthcare calls its Vivid i 'the virtual stethoscope of future'

Oct. 1, 2004

By Holland Johnson

Abbott enrolls first patient in study of its ZoMaxx DES

Oct. 1, 2004

By Holland Johnson

ReValving may change valve replacement and open-heart surgery

Aug. 1, 2004

By Holland Johnson

St. Jude becomes third company with entry in U.S. CRT-D market

Aug. 1, 2004

By Holland Johnson

Medtronic, Genzyme form j-v for cardio disease therapies

July 1, 2004

By Holland Johnson

Two firms' cardiac diagnostic tests are cleared for sale by FDA

June 1, 2004

By Holland Johnson

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...